Skip to content

Effects of ingesting heat-killed bifidobacteria for 5 weeks on the oral condition

Effects of ingesting heat-killed bifidobacteria for 5 weeks on the salivary IgA: A randomized, double-blind, placebo-controlled, parallel-group study - Effects of ingesting heat-killed bifidobacteria for 5 weeks on the salivary IgA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000053172
Enrollment
30
Registered
2023-12-20
Start date
2013-09-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N/A (Healthy adults)

Interventions

Test food: One g of granule dextrin contained 40 mg of non-live bifidobacteria powder (more than 0.5 x 10^10 non-live cells per 1 g of the test food) Administration: Oral intake of test food twice a

Sponsors

Meiji Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Healthy females of 20 to 40 years age 2. Subjects with more than 4 measurable teeth in the 6 index teeth (teeth nos. 16, 21, 24, 36, 41, and 44) or substitutional neighboring teeth (teeth nos. 17, 15, 11, 22, 25, 37, 35, 31, 42, 45) 3. Subjects without undergoing treatment for caries or periodontal disease 4. Subjects with more than 20 teeth 5. Subjects giving written informed consent

Exclusion criteria

Exclusion criteria: 1. Subjects with severe caries or periodontal disease 2. Subjects with removable dentures 3. Subjects who have took in antibiotic or antibacterial agent within the last month to the screening test 4. Pregnant, possibly pregnant during this study, or lactating women 5. Subjects with sever systemic diseases affecting the results of this study

Design outcomes

Primary

MeasureTime frame
Salivary IgA and IgA per mg of protein

Secondary

MeasureTime frame
Oral condition and safety

Countries

Japan

Contacts

Public ContactEiji Yoshikawa

KSO Corporation Clinical Trial Management department

eigyou27@kso.co.jp81-3-3452-7733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026